Literature DB >> 14579029

MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632.

P Gual1, T Grémeaux, T Gonzalez, Y Le Marchand-Brustel, J-F Tanti.   

Abstract

AIM/HYPOTHESIS: Insulin-induced IRS-1 serine phosphorylation could be physiologically important to regulate insulin action. In a hyperinsulinaemic state such as obesity or Type 2 diabetes, this phosphorylation could be modified and exacerbate insulin resistance. We aimed at identifying serine residues in IRS-1 phosphorylated in response to insulin stimulation and at determining the involved kinases.
METHODS: 3T3-L1 adipocytes, muscle and adipose tissue of mice were subjected to Western Blot analysis with phosphospecific antibodies to identify phosphorylation sites in IRS-1 following insulin treatment. Pharmacological inhibitors were used to determine the serine kinases involved in this phosphorylation.
RESULTS: In 3T3-L1 adipocytes, insulin promoted the phosphorylation of serine 307, 612 and 632 with Serine(612/632) more rapidly phosphorylated than Serine(307). Insulin-induced phosphorylation of Serine(307) was dependent on the activation of a PI 3-kinase/mTOR pathway. The phosphorylation of Serine(612/632) required the activation of the MAP kinase pathway following short-term insulin stimulation and activation of the PI 3-kinase/mTOR pathway following prolonged insulin stimulation. Phosphorylation of Serine(307) and Serine(632) occurred in vivo in skeletal muscle and white adipose tissue of mice injected with insulin and was dependent on the activation of mTOR. Moreover, inhibition of mTOR led to a persistent PI 3-kinase activation by insulin. CONCLUSION/
INTERPRETATION: Insulin-induced IRS-1 serine phosphorylation is a complex process involving different sites and kinases. This complexity could be physiologically important to accurately regulate insulin signalling. Abnormal phosphorylation of these serine residues in hyperinsulinaemic state could participate in the down-regulation of insulin signalling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579029     DOI: 10.1007/s00125-003-1223-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  41 in total

1.  Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM.

Authors:  E Carvalho; P A Jansson; M Axelsen; J W Eriksson; X Huang; L Groop; C Rondinone; L Sjöström; U Smith
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

2.  Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation.

Authors:  Michael W Greene; Robert S Garofalo
Journal:  Biochemistry       Date:  2002-06-04       Impact factor: 3.162

3.  Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle.

Authors:  Chunli Yu; Yan Chen; Gary W Cline; Dongyan Zhang; Haihong Zong; Yanlin Wang; Raynald Bergeron; Jason K Kim; Samuel W Cushman; Gregory J Cooney; Bronwyn Atcheson; Morris F White; Edward W Kraegen; Gerald I Shulman
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

4.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.

Authors:  F Tremblay; A Marette
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

5.  Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation.

Authors:  T M Pederson; D L Kramer; C M Rondinone
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

6.  Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase.

Authors:  K De Fea; R A Roth
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

7.  Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.

Authors:  K De Fea; R A Roth
Journal:  Biochemistry       Date:  1997-10-21       Impact factor: 3.162

8.  A central role for JNK in obesity and insulin resistance.

Authors:  Jiro Hirosumi; Gürol Tuncman; Lufen Chang; Cem Z Görgün; K Teoman Uysal; Kazuhisa Maeda; Michael Karin; Gökhan S Hotamisligil
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

9.  Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling.

Authors:  J F Tanti; T Grémeaux; E van Obberghen; Y Le Marchand-Brustel
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

10.  Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells.

Authors:  D L Esposito; Y Li; A Cama; M J Quon
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

View more
  44 in total

Review 1.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

2.  Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.

Authors:  Nancy J Hançer; Wei Qiu; Christine Cherella; Yedan Li; Kyle D Copps; Morris F White
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

3.  Mechanism of feedback regulation of insulin receptor substrate-1 phosphorylation in primary adipocytes.

Authors:  Ingeborg Hers; Jeremy M Tavaré
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

4.  Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.

Authors:  Saskia M Brachmann; Kohjiro Ueki; Jeffrey A Engelman; Ronald C Kahn; Lewis C Cantley
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport.

Authors:  C D'Alessandris; R Lauro; I Presta; G Sesti
Journal:  Diabetologia       Date:  2007-02-06       Impact factor: 10.122

Review 6.  Insulin resistance and atherosclerosis.

Authors:  Babak Razani; Manu V Chakravarthy; Clay F Semenkovich
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

7.  Burn injury-induced IRS-1 degradation in mouse skeletal muscle.

Authors:  X-M Lu; Rg Tompkins; Aj Fischman
Journal:  Int J Burns Trauma       Date:  2013-01-24

8.  Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy.

Authors:  Michelle B Hookham; Helen C O'Donovan; Rachel H Church; Annie Mercier-Zuber; Lucilla Luzi; Simon P Curran; Rosemarie M Carew; Alejandra Droguett; Sergio Mezzano; Markus Schubert; Morris F White; John K Crean; Derek P Brazil
Journal:  FEBS J       Date:  2013-05-29       Impact factor: 5.542

9.  Hypoxia decreases insulin signaling pathways in adipocytes.

Authors:  Claire Regazzetti; Pascal Peraldi; Thierry Grémeaux; Rosanna Najem-Lendom; Issam Ben-Sahra; Mireille Cormont; Frédéric Bost; Yannick Le Marchand-Brustel; Jean-François Tanti; Sophie Giorgetti-Peraldi
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

10.  Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis.

Authors:  Jennifer Jager; Thierry Grémeaux; Teresa Gonzalez; Stéphanie Bonnafous; Cyrille Debard; Martine Laville; Hubert Vidal; Albert Tran; Philippe Gual; Yannick Le Marchand-Brustel; Mireille Cormont; Jean-François Tanti
Journal:  Diabetes       Date:  2009-10-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.